Ranibizumab
-
Lupin, Amman Pharma in agreement for Ranibizumab Biosimilar
Pioneering access to this complex ophthalmic biosimilar medicine in the MENA Region Lupin has partnered with Amman Pharmaceuticals Industries (Amman…
Read More » -
Intas, Axantia sign exclusive license and supply agreement for Ranibizumab biosimilar in Middle East
Axantia will register, hold the marketing authorisation and commercialise Ranibizumab Intas Pharmaceuticals has signed an exclusive license and supply agreement…
Read More »